The ghost of Crozer Health looms large over Pennsylvania’s legislative chambers, casting a long shadow that now fuels a bipartisan push to rein in the often-unseen forces of private equity in healthcare.
Last month’s closure of what was once a sprawling four-hospital system in Delaware County ripped a gaping hole in the region’s healthcare infrastructure, leaving behind a trail of laid-off employees, anxious patients, and a community grappling with a profound sense of abandonment.
The culprits, according to local lawmakers and nurses’ unions, are clear: profit-seeking private equity groups whose relentless pursuit of quick returns allegedly left the system financially gutted and mired in crushing debt.
“These were actions that were purposely taken by this for-profit entity, and they were taken because they could,” lamented Pennsylvania state Sen. Tim Kearney, a Democrat representing parts of Delaware County, his words echoing the frustration of many.
“It wasn’t illegal what they did.”
This grim reality – that a healthcare system could be legally dismantled for profit, leaving a community bereft – has ignited a fierce resolve in Harrisburg to ensure such a saga is never repeated.
Last week, the Pennsylvania House of Representatives took a significant stride, passing a bill with a decisive 121-82 vote that seeks to inject state oversight into the opaque world of healthcare transactions.
The proposed legislation, known as the Health Care Services Protection Act, isn’t limited to hospitals; its reach extends to ambulatory surgical centers, rehabilitation hospitals, long-term-care nursing facilities, certain cancer treatment centers, inpatient drug and alcohol treatment facilities, and hospices.
At its heart, the bill empowers the state’s attorney general to scrutinize proposed sales, mergers, and acquisitions involving for-profit and private equity companies, with the power to block deals deemed “against the public interest.”
The mechanism is straightforward: for transactions worth $10 million or more, the attorney general would search for “clear and convincing evidence” that a deal could lead to increased costs for patients, a reduction in quality of care, diminished access to services, or stifled market competition.
The bill even grants the attorney general the authority to hold public hearings and enlist external consultants, bringing a much-needed layer of transparency to what have historically been backroom deals.
Crucially, it also allows for a five-to-ten-year monitoring period post-transaction, specifically targeting insidious practices like leaseback agreements – where a hospital’s land is sold off, turning the facility into a tenant burdened by rent, a strategy that drained Crozer Health and Sharon Regional Medical Center in Mercer County.
“We will not see the surprise stripping of assets of the acquired facility under this legislation as we’ve seen in Mercer County and as we’ve seen in Delaware County,” asserted Republican Timothy Bonner, who represents Mercer County and whose community saw Sharon Regional temporarily close.
His endorsement underscores the bipartisan anxiety over these practices.
Yet, this legislative effort is not without its detractors, who raise legitimate concerns about potential overreach and unintended consequences.
House Republican Leader Jesse Topper, who voted against the bill, voiced apprehension that increased oversight could deter “well-intentioned, needed private equity investments.”
There’s a valid argument to be made that in some underserved areas or for struggling facilities, private investment, with its promise of capital and operational efficiency, can indeed be a lifeline.
However, proponents are quick to clarify that the bill isn’t a blanket ban on private equity in healthcare.
“We have heard that there are instances where private equity can be a lifeline to service providers. We are not interested in preventing care or making access more challenging,” affirmed Democrat Lisa Borowski, the bill’s prime sponsor.
“We are interested in making sure bad actors do not come to our commonwealth, target struggling health care facilities and sell off the parts for personal gain.”
The bill even includes a provision allowing a for-profit entity to acquire a facility if it’s the only viable option to prevent a closure or significant service loss, even if its long-term plans are less than ideal.
This acknowledges the complex tightrope walk between preventing exploitation and ensuring continuity of care.
Even among the bill’s supporters, there’s a sense that the legislation could have gone further.
Republican Craig Williams, who represents Chester County and lives in Delaware County, characterized the final House version as “weaker” due to amendments that increased the burden of proof for the attorney general.
“But sometimes, you just have to do a little bit of good,” Williams conceded, acknowledging the pragmatic compromises necessary for any legislative progress.
His hope, shared by many, is that the bill will stand as a bulwark against future healthcare depredations.
The true test now lies in the Pennsylvania Senate, where the bill faces a new set of hurdles.
Previous attempts at similar oversight laws have faltered, but Senator Kearney believes the Crozer Health debacle provides a compelling, undeniable cautionary tale.
He’s banking on the pragmatism of Republican senators whose districts may house hospitals teetering on the brink, ripe for the private equity playbook.
The Senate’s newly formed Institutional Sustainability and Innovation Committee is poised to consider the bill, and changes are anticipated.
Discussions are expected to revolve around the inclusion of doctors’ practices and nursing homes, sectors where private equity plays a significant, often essential, role in business operations.
This delicate balancing act – protecting vulnerable patients without stifling necessary investment – will define the upcoming debates.
Historically, the Hospital and Healthsystem Association of Pennsylvania (HAP) has been a formidable opponent of such oversight, particularly when older versions of the bill included nonprofit hospitals, which they argue are already subject to rigorous federal and state oversight.
This time, however, lawmakers have engaged closely with HAP, signaling a more collaborative approach.
While HAP President and CEO Nicole Stallings stated the association couldn’t fully support the current House version, she emphasized a commitment to continued engagement, seeking to refine the language to avoid “unintended consequences” and ensure the bill doesn’t discourage beneficial investments.
The fear, often articulated by industry groups, is that Pennsylvania could become an outlier, deterring transactions that genuinely aim to enhance, rather than diminish, community access to care.
The legislative journey of the Health Care Services Protection Act is a microcosm of a larger national struggle: how to regulate the increasingly powerful and often opaque world of private capital when it intersects with essential public services.
As the echoes of Crozer Health’s closure continue to reverberate, Pennsylvania stands at a critical juncture, attempting to draw a line in the sand, asserting that healthcare, at its core, is a public trust, not merely a commodity to be bought, sold, and stripped for parts.
The outcome in the Senate will determine whether this line holds, or if the private equity playbook will continue to operate unchecked, leaving more communities to mourn the loss of vital institutions.
